Alivus Life Sciences Limited (BOM:543322)
1,008.60
-36.85 (-3.52%)
At close: Apr 28, 2026
-2.49% (1Y)
| Market Cap | 123.68B |
| Revenue (ttm) | 25.12B |
| Net Income (ttm) | 5.44B |
| Shares Out | n/a |
| EPS (ttm) | 44.23 |
| PE Ratio | 22.75 |
| Forward PE | 17.39 |
| Dividend | 5.00 (0.48%) |
| Ex-Dividend Date | Sep 1, 2025 |
| Volume | 6,909 |
| Average Volume | 5,539 |
| Open | 1,055.75 |
| Previous Close | 1,045.45 |
| Day's Range | 999.90 - 1,057.65 |
| 52-Week Range | 830.00 - 1,224.00 |
| Beta | n/a |
| RSI | 47.13 |
| Earnings Date | Apr 30, 2026 |